Comparative efficacy of teriparatide and bisphosphonates or denosumab vs. teriparatide monotherapy in osteoporosis: a meta-analysis

Comparative efficacy of teriparatide and bisphosphonates or denosumab vs. teriparatide monotherapy in osteoporosis: a meta-analysis

IntroductionTeriparatide (TPTD), a widely used bone-promoting drug in osteoporosis (OP) treatment, may cause compensatory bone resorption with long-term monotherapy (>6 months). Combining TPTD with anti-bone resorption drugs (e.g., bisphosphonates and denosumab) could reduce bone loss, yet ex...

Full description

Saved in:

Bibliographic Details
Main Authors:	Huan Jin, Cai Huang, Yan Zhang, Ying Dong, Qi Xiong, Di Wang, Ziyi He, Lin Shen, Chen Ma, Zixian Wang, Bo Shuai
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-05-01
Series:	Frontiers in Pharmacology
Subjects:	osteoporosis teriparatide monotherapy bisphosphonates denosumab vertebral fractures bone mineral density
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2025.1605279/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Efficacy and safety of abaloparatide, denosumab, teriparatide, oral bisphosphonates, and intravenous bisphosphonates in the treatment of male osteoporosis: a systematic review and Bayesian network meta-analysis
by: Liangshi Chen, et al.
Published: (2025-04-01)

Combination or sequential teriparatide for osteoporosis treatment in denosumab-users: real-world bone mineral density outcomes
by: Shejil KUMAR, et al.
Published: (2025-06-01)

Current treatment of osteoporosis
by: Subramanian Nallasivan
Published: (2019-01-01)

The efficacy and safety of denosumab, risedronate, alendronate and teriparatide to treat male osteoporosis: a systematic review and bayesian network meta-analysis
by: Shu Jun Chai, et al.
Published: (2025-06-01)

Multiple Myeloma Case Developed During the Use of the Teriparatide
by: Zehra Erdemir, et al.
Published: (2022-04-01)

Timing optimization of teriparatide dosing for postmenopausal osteoporosis: a randomized controlled trial
by: Huan Wang, et al.
Published: (2025-07-01)

The Russian Council of Experts for Use of the Innovative Anabolic Agent Forsteo®(Teriparatide) in the Treatment of Severe Osteoporosis
by: Olga Mikhailovna Lesnyak
Published: (2013-10-01)

Superiority of denosumab over bisphosphonates in preventing and treating glucocorticoid-induced osteoporosis: a systematic review and meta-analysis with GRADE quality assessment
by: Chiao-Ling Chen, et al.
Published: (2024-12-01)

A Phase 3 Multicenter, Double‐Blind Study Comparing Efficacy, Safety, Immunogenicity, and Pharmacokinetics of Alkem's Biosimilar Teriparatide Versus Reference Teriparatide in Postmenopausal Osteoporosis
by: Nitin Kapoor, et al.
Published: (2025-06-01)

Incidence of Total Knee Arthroplasty in Older Females with Knee Osteoarthritis and Osteoporosis Treated with Denosumab Compared with Those Treated Using Bisphosphonates: A Population-Based Cohort Study
by: Tzai-Chiu Yu, et al.
Published: (2024-12-01)

Effects of Teriparatide and Alendronate on Functional Recovery from Spinal Cord Injury and Postinjury Bone Loss
by: Shuai Wang, et al.
Published: (2025-02-01)

Suitability of teriparatide and level of acceptance of pharmacotherapeutic recommendations in a healthcare management areaSuitability of teriparatide and level of acceptance of pharmacotherapeutic recommendations in a healthcare management area DOI: 10.7399/fh.2016.40.4.9953
by: Maria Rosa Cantudo-Cuenca, et al.
Published: (2016-07-01)

Denosumab Related Osteonecrosis of Jaw: a Case Report
by: Marco Vinícius de Sales Lima, et al.
Published: (2018-12-01)

Denosumab is the first gene engineered agent for the treatment of osteoporosis
by: O A Nikitinskaya, et al.
Published: (2012-09-01)

EXPERIENCE OF LONG-TERM TERIPARATIDE USE FOR THE TREATMENT OF POSTOPERATIVE HYPOPARATHYROIDISM ASSOCIATED WITH OSTEOPOROSIS IN ELDERLY PATIENT
by: G. A. Batrak, et al.
Published: (2018-11-01)

Impacts of Prior Anti-Osteoporosis Treatments on Sequential Denosumab Responses in BMD Changes Among Postmenopausal Osteoporosis Women in East China: Real-World Data Analysis
by: Guan G, et al.
Published: (2025-05-01)

Treatment of patients with osteoporosis: issues of therapy duration, adherence, and replacement
by: N. V. Toroptsova
Published: (2018-12-01)

Denosumab and the Rebound Effect: Current Aspects of Osteoporosis Therapy (Review)
by: N. Yu. Velts, et al.
Published: (2024-07-01)

Efficacy of Bisphosphonates for the Treatment of Osteoporosis in Patients with Multiple Sclerosis
by: İlke Coşkun Benlidayı, et al.
Published: (2015-08-01)

Teriparatidin ilaçlarla ilişkili çene osteonekrozu tedavisindeki etkinliği: hayvan çalışması
by: Cihan Topan, et al.
Published: (2020-08-01)

Therapeutic effects of teriparatide on subchondral bone lesions and pain in mono-iodoacetate-induced osteoarthritis rat model
by: Koji Aso, et al.
Published: (2025-09-01)

A randomized controlled trial of teriparatide for accelerating bone union and improving clinical outcomes in patients with pertrochanteric fracture fixation
by: Chotetawan Tanavalee, et al.
Published: (2025-06-01)

Vertebral osteoporotic fractures: differential diagnosis, therapeutic approaches
by: N. A. Shostak, et al.
Published: (2024-12-01)

A Rare Cause of Back Pain after Pregnancy: Postpartum Osteoporosis and Treatment Approach
by: Muzaffer İlhan, et al.
Published: (2016-12-01)

Treatment period and changes in bone markers according to the application of teriparatide in treating medication-related osteonecrosis of the jaw
by: Jin Hoo Park, et al.
Published: (2025-04-01)

A Multifunctional Nanodelivery System Modified by Fusion Peptides Acts as Teriparatide Carrier for Noise‐Induced Hearing Loss Therapy
by: Jiawen Li, et al.
Published: (2025-08-01)

Bisphosphonates in the Management of Patients with Postmenopausal Osteoporosis; Back to the Future
by: Socrates E. Papapoulos, et al.
Published: (2025-07-01)

Experimental study of the effect of teriparatide on a medication-related rat model of osteonecrosis of the jaw
by: LIAO Chenyu, et al.
Published: (2024-02-01)

The Effects of Denosumab Treatment on Pain and Function Beyond Bone Density in Patients With Postmenopausal Osteoporosis: A Prospective Study
by: Miao Zheng, et al.
Published: (2025-06-01)

New possibilities for the treatment of glucocorticoid-induced osteoporosis
by: I.A. Baranova
Published: (2014-05-01)

Impact of Teriparatide Acetate on Caspase-9 Gene Expression in Relation to Histological and Tunnel Assay of Apoptosis in Rat Kidneys and Livers
by: Saif Al-Jammas, et al.
Published: (2025-01-01)

The use of bisphosphonates for the treatment and prevention of osteoporosis
by: O. A. Nikitinskaya, et al.
Published: (2022-08-01)

Effectiveness of Denosumab in Postmenopausal Osteoporosis Treatment: A 1-yr Follow-up Single-center Study
by: Nihal Tezel, et al.
Published: (2021-12-01)

A randomized controlled trial comparing romosozumab and denosumab in elderly women with primary osteoporosis and knee osteoarthritis
by: Yasumori Sobue, et al.
Published: (2025-07-01)

glucocorticoid osteoporosis; osteoporotic fracture; bisphosphonates; FRAX algorithm
by: Natalia Vladimirovna Toroptsova, et al.
Published: (2013-12-01)

Advances in the Study of Denosumab Treatment for Osteoporosis and Sarcopenia in the Chinese Middle-Aged and Elderly Population
by: Li S, et al.
Published: (2024-12-01)

Efficacy evaluation of denosumab in the treatment of patients with postmenopausal osteoporosis at high risk of fracture
by: Jing ZHOU, et al.
Published: (2025-02-01)

Experience with denosumab therapy for osteoporosis in rheumatoid arthritis patients receiving glucocorticoids
by: I. S. Dydykina, et al.
Published: (2018-06-01)

Role of Denosumab and Zoledronic Acid in Geriatric Hip Fractures – A Comparative Analysis
by: P Madhuchandra, et al.
Published: (2024-01-01)

Association of Delayed Denosumab Dosing with Increased Risk of Fractures: A Population-Based Retrospective Study
by: Kyoung Min Kim, et al.
Published: (2024-12-01)